Allergan USA, Inc. et al v. Hetero Labs Limited et al
| Allergan USA, Inc., Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company and Allergan Pharmaceuticals International Limited |
| Hetero Labs Limited and Hetero USA, Inc. |
| 1:2020cv01344 |
| October 5, 2020 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 20, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 20 STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to December 4, 2020 - filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) |
SO ORDERED, re #20 STIPULATION and Proposed Order to extend time to Submit Proposed Protective Order to December 4, 2020. Signed by Judge Richard G. Andrews on 11/20/2020. (nms)
|
| Filing 19 NOTICE OF SERVICE of Rule 26(a) Initial Disclosures and Paragraph 3 Disclosures filed by Hetero Labs Limited, Hetero USA, Inc..(Ormerod, Eve) |
| Filing 18 NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1), (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, and (3) Plaintiffs' Initial Paragraph 4(a) Disclosures filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy) |
|
Filing 17
ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 12/18/2020 at 11:30 AM Eastern Time with Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 11/2/20. (cak)
|
|
Filing 16
ORAL ORDER: The Rule 16(b) Conference set for 11/4/2020, is CANCELED. Ordered by Judge Richard G. Andrews on 11/2/2020. (nms)
|
|
Filing 15
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/12/2021. Amended Pleadings due by 3/12/2021. Fact Discovery completed by 5/14/2021. A Status Conference is set for 1/7/2022, at 9:00 AM in Courtroom 6A. Joint Claim Construction Brief due by 4/9/2021. A Markman Hearing is set for 5/5/2021, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 4/15/2022, at 9:00 AM in Courtroom 6A. A Bench Trial is set to start 5/2/2022, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 11/2/2020. (nms)
|
| Filing 14 PROPOSED Scheduling Order, by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 11/2/2020 (nms). |
| CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| Filing 13 Letter to The Honorable Richard G. Andrews, from Jeremy A. Tigan, regarding dial-in number for scheduling conference on November 4, 2020. (Tigan, Jeremy) Modified on 10/16/2020 (nms). |
|
Filing 12
Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 11/4/2020, at 2:00 PM (see Order for further details). Signed by Judge Richard G. Andrews on 10/15/2020. (nms)
|
| Pro Hac Vice Attorney Dmitry V. Shelhoff,Edward D. Pergament,Kenneth S. Canfield for Hetero Labs Limited and Hetero USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Labs, Ltd., Corporate Parent Hetero Drugs Ltd. for Hetero USA, Inc. filed by Hetero Labs Limited, Hetero USA, Inc.. (Belgam, Neal) |
| Filing 10 ANSWER to #1 Complaint, and Additional Defenses by Hetero Labs Limited, Hetero USA, Inc..(Belgam, Neal) Modified on 10/13/2020 (nms). |
| Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Edward D. Pergament, and Kenneth S. Canfield - filed by Hetero Labs Limited, Hetero USA, Inc.. (Ormerod, Eve) |
| Filing 8 SUMMONS Returned Executed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. Hetero Labs Limited served on 10/7/2020, answer due 10/28/2020. (Tigan, Jeremy) |
| Filing 7 SUMMONS Returned Executed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. Hetero USA, Inc. served on 10/7/2020, answer due 10/28/2020. (Tigan, Jeremy) |
|
SO ORDERED, re #9 MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Edward D. Pergament, and Kenneth S. Canfield, filed by Hetero Labs Limited, Hetero USA, Inc.. Signed by Judge Richard G. Andrews on 10/9/2020. (nms)
|
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (kmd) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceutica NV; Corporate Parent Abbvie, Inc. for Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc. - filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (kmd) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,741,356 B2. (kmd) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: n/a. Date of Expiration of Patent: 5/27/2029.Thirty Month Stay Deadline: 4/2/2023. (kmd) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Filing 1 COMPLAINT filed against Hetero Labs Limited, Hetero USA, Inc. - Magistrate Consent Notice to Pltf. (Filing fee $400, receipt number ADEDC-3241437.) - filed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(kmd) (Attachment 2 replaced on 10/5/2020) (kmd). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
